Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Oncology (Williston Park, N.Y.)
|
June 20, 2015
Lymphoepithelioma-Like Carcinoma of the Urinary Bladder
Elizabeth R Kessler, Arya Amini, Shandra S Wilson, et al.
Oncology (Williston Park, N.Y.)
|
March 17, 2017
Seventy-Year-Old Man With Large Bladder Mass: Diagnostic and Clinical Challenges of an Uncommon Neoplasm
Tamara P Lhungay, Alexandra Colvin, Jason Warncke, et al.
Nature Clinical Practice. Nephrology
|
January 29, 2009
A case of tuberous sclerosis complex that progressed to end-stage renal disease
Mohammad Sarraf, Amirali Masoumi, Fernando J Castro-Silva, et al.
The Journal of Urology
|
October 25, 2011
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro
Abdalla Ali Deb, Shandra S Wilson, Kyle O Rove, et al.
BJU International
|
October 18, 2005
Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy
E David Crawford, Shandra S Wilson, Kathleen C Torkko, et al.
The Journal of Urology
|
April 20, 2013
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin
Eila C Skinner, Bryan Goldman, Wael A Sakr, et al.
The Prostate
|
February 21, 2018
The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer
Michael A Maccini, Nicholas J Westfall, Adrie Van Bokhoven, et al.
The Journal of Urology
|
March 7, 2006
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo
E David Crawford, Shandra S Wilson, John D McConnell, et al.
European Urology
|
March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial
Cheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
The Journal of Urology
|
December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial
Teresa L Kauf, Robert S Svatek, Gilad Amiel, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Oncology (Williston Park, N.Y.)
|
June 20, 2015
Lymphoepithelioma-Like Carcinoma of the Urinary Bladder
Elizabeth R Kessler, Arya Amini, Shandra S Wilson, et al.
Oncology (Williston Park, N.Y.)
|
March 17, 2017
Seventy-Year-Old Man With Large Bladder Mass: Diagnostic and Clinical Challenges of an Uncommon Neoplasm
Tamara P Lhungay, Alexandra Colvin, Jason Warncke, et al.
Nature Clinical Practice. Nephrology
|
January 29, 2009
A case of tuberous sclerosis complex that progressed to end-stage renal disease
Mohammad Sarraf, Amirali Masoumi, Fernando J Castro-Silva, et al.
The Journal of Urology
|
October 25, 2011
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro
Abdalla Ali Deb, Shandra S Wilson, Kyle O Rove, et al.
BJU International
|
October 18, 2005
Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy
E David Crawford, Shandra S Wilson, Kathleen C Torkko, et al.
The Journal of Urology
|
April 20, 2013
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin
Eila C Skinner, Bryan Goldman, Wael A Sakr, et al.
The Prostate
|
February 21, 2018
The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer
Michael A Maccini, Nicholas J Westfall, Adrie Van Bokhoven, et al.
The Journal of Urology
|
March 7, 2006
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo
E David Crawford, Shandra S Wilson, John D McConnell, et al.
European Urology
|
March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial
Cheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
The Journal of Urology
|
December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial
Teresa L Kauf, Robert S Svatek, Gilad Amiel, et al.
Page
of 3